Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung

NCT05807893 2024-11-13

SUPER BRAIN

Phase 2/3 Completed

40 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT00227617 2023-05-22

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

Phase 2/3 Terminated

36 enrolled 14 charts

EndocrineNETThoracic

Vipoma, Glucagonoma, Insulinoma, Adenoma, Islet Cell, Lung Neoplasms, Neoplasms, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell, Neuroendocrine Tumors

NCT00651456 2023-03-13

MAPS

Phase 2/3 Completed

448 enrolled

Other solid neoplasmThoracic

Mesothelioma

NCT01383148 2017-01-05

TIME

Phase 2/3 Terminated

222 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00930891 2016-03-10

CPC

Phase 2/3 Completed

143 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT00021060 2013-02-27

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer

Phase 2/3 Completed

842 enrolled

Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

Clinical Trials

B-FAST

SUPER BRAIN

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

MAPS

TIME

CPC

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer